Stem cell abnormalities in esophagus may lead to Barrett's esophagus
the ONA take:
According to new findings published in the journal Cell Reports, researchers at the University of Pittsburgh School of Medicine in Pittsburgh, Pennsylvania, have found that the esophagus has its own pool of stem cells despite previous findings that suggest the opposite.
The findings of the study could help in better understanding the causes of esophageal cancer and Barrett's esophagus, as well as lead to the development of new treatment options. The researchers knew that cells in the inner layers of the esophagus divide twice weekly to produce cells that ultimately become the specialized cells of the lining of the esophagus. The dying cells slough off into the gastrointestinal tract.
This study determined that there is a subpopulation of stem cells in the deeper layers of the esophagus, disproving the belief that all the cells in the deeper layers are the same.
Stem cells are more likely to rest rather than divide, so it was believed that there were no stem cells in the esophagus due to the regular division of cells. The researchers found that these stem cells divide slowly whereas the other cells in the deeper layers divide regularly. Future studies must be conducted to determine if esophageal stem cell abnormalities lead to Barrett's esophagus.
The esophagus has its own pool of stem cells despite previous findings that suggest the opposite.
Despite previous indications to the contrary, the esophagus does have its own pool of stem cells, said researchers from the University of Pittsburgh School of Medicine in an animal study published online today in Cell Reports. The findings could lead to new insights into the development and treatment of esophageal cancer and the precancerous condition known as Barrett's esophagus.
According to the American Cancer Society, more than 18,000 people will be diagnosed with esophageal cancer in the U.S. in 2014 and almost 15,500 people will die from it. In Barrett's esophagus, the lining of the esophagus changes for unknown reasons to resemble that of the intestine, though gastro-esophageal reflux disease or GERD is a risk factor for its development.
Sign Up for Free e-newsletters
- Managing Chemo Brain in Pediatric Survivors of Childhood Cancer
- Aggressive Therapy Provides No Additional Advantage in Metastatic Prostate Cancer
- Excretion of Volatile Organic Compounds Higher in AYAs Using Vaping Products
- FDA, ASHP Actions to Prevent or Manage Chemotherapy Drug Shortages
- Breast Cancer Screening Recommendations Not Completely Reflective of Race, Age
- Various Aspects of Palliative Care Focus Associated With Different Outcomes In Cancer
- Cost vs Benefits: The Controversy Over Proton Beam Radiotherapy
- Patient Expectations at Odds With Actual Outcomes for Radiotherapy in Breast Cancer
- Patients Desire More Online Tools and Access
- Metformin Plus Ruxolitinib: A Potential Therapeutic Alternative for Myeloproliferative Neoplasms
- Sexual Quality of Life Decreased During, After Chemotherapy for Digestive Cancers
- CHEMO-SUPPORT: A Nursing Intervention to Relieve Chemotherapy Symptom Burden
- Approach and Management of Checkpoint Inhibitor-related Immune Hepatitis
- Revised AJCC8 Demonstrates Superior Tumor Classification for HNCSCC
- Oral Androgen Receptor Inhibitor Granted FDA Approval for Nonmetastatic CRPC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|